Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Management changes at Actelion

This article was originally published in Scrip

Executive Summary

Actelion (Switzerland) has appointed its head of clinical development, Isaac Kobrin, to the newly created position of chief medical officer, effective July 1st. Guy Braunstein will assume the role of head of clinical development; he joins the company having served as chief medical officer at Merck Serono and, before that, as chief medical officer at Serono International.

Topics

UsernamePublicRestriction

Register

SC002606

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel